PMID- 18599338 OWN - NLM STAT- MEDLINE DCOM- 20081008 LR - 20161124 IS - 1357-2725 (Print) IS - 1357-2725 (Linking) VI - 40 IP - 11 DP - 2008 TI - A new mouse model of Peyronie's disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes. PG - 2638-48 LID - 10.1016/j.biocel.2008.05.012 [doi] AB - Peyronie's disease (PD) is characterized by an inflammatory response beneath the tunica albuginea with fibroblast proliferation forming a thickened fibrous plaque that may cause pain, penile curvature and erectile dysfunction. The progression of the PD plaque may eventually lead to calcification or ossification. Current therapeutic success is often unsatisfactory because of limited insight into disease mechanisms. Research has been hampered by the lack of a universally accepted animal model. We describe an animal model of spontaneous PD in tight skin (Tsk) mice, a C57Bl/6J subline that reproduces with age important features of the human disease (fibrous plaque formation, penile bending and areas of chondroid metaplasia with heterotopic ossification). Histological analysis demonstrated an evident structural disorganization of the tunica albuginea with excessive accumulation of type I collagen. At 12 months of age, fibrous plaques with areas of chondroid metaplasia and heterotopic ossification characterized Tsk penises. The up-regulation of hypoxia-inducible factor-1 (HIF-1) leads to an increased downstream expression of HIF-1 target genes, such as TGFbeta and iNOS. These factors, together with some PDGF family members, can cause collagen deposition in Tsk penises. They can also influence chondrocyte differentiation and heterotopic bone formation. In conclusion, hypoxia, HIF-1 and HIF-1 target genes appear to play an important role in the pathogenesis of PD in Tsk mice. This mouse model that is the first example of naturally occurring model of PD in laboratory animals may aid in the identification of signalling pathways crucial for PD and should facilitate the designing and testing of new therapeutic interventions. FAU - Lucattelli, Monica AU - Lucattelli M AD - Dipartimento di Fisiopatologia, Medicina Sperimentale e Sanita Pubblica, Universita di Siena, Italy. FAU - Lunghi, Benedetta AU - Lunghi B FAU - Fineschi, Silvia AU - Fineschi S FAU - Mirone, Vincenzo AU - Mirone V FAU - d'Emmanuele di Villa Bianca, Roberta AU - d'Emmanuele di Villa Bianca R FAU - Longo, Nicola AU - Longo N FAU - Imbimbo, Ciro AU - Imbimbo C FAU - De Palma, Raffaele AU - De Palma R FAU - Sorrentino, Raffaella AU - Sorrentino R FAU - Lungarella, Giuseppe AU - Lungarella G FAU - Cirino, Giuseppe AU - Cirino G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080528 PL - Netherlands TA - Int J Biochem Cell Biol JT - The international journal of biochemistry & cell biology JID - 9508482 RN - 0 (Collagen Type I) RN - 0 (Collagen Type II) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (Transforming Growth Factor beta) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) SB - IM MH - Animals MH - Collagen Type I/genetics/metabolism MH - Collagen Type II/genetics/metabolism MH - *Disease Models, Animal MH - Female MH - *Gene Expression Regulation MH - Humans MH - Hypoxia MH - Hypoxia-Inducible Factor 1/genetics/*metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Nitric Oxide Synthase Type II/genetics/metabolism MH - *Penile Induration/genetics/pathology MH - Penis/anatomy & histology/*pathology MH - Transforming Growth Factor beta/metabolism EDAT- 2008/07/05 09:00 MHDA- 2008/10/09 09:00 CRDT- 2008/07/05 09:00 PHST- 2008/03/17 00:00 [received] PHST- 2008/05/05 00:00 [revised] PHST- 2008/05/14 00:00 [accepted] PHST- 2008/07/05 09:00 [pubmed] PHST- 2008/10/09 09:00 [medline] PHST- 2008/07/05 09:00 [entrez] AID - S1357-2725(08)00210-0 [pii] AID - 10.1016/j.biocel.2008.05.012 [doi] PST - ppublish SO - Int J Biochem Cell Biol. 2008;40(11):2638-48. doi: 10.1016/j.biocel.2008.05.012. Epub 2008 May 28.